Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension

Documenti analoghi

• Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin‐treated glaucoma patients
  di: Aihara, Makoto, et al.
  Pubblicazione: (2017)
• Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
  di: Beckers, Henny JM, et al.
  Pubblicazione: (2009)
• Additive intraocular pressure-lowering effect of dorzolamide 1%/timolol 0.5% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma
  di: Mizoguchi, Takanori, et al.
  Pubblicazione: (2011)
• Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma
  di: Hommer, Anton, et al.
  Pubblicazione: (2015)
• Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice
  di: Lanzl, Ines, et al.
  Pubblicazione: (2011)